Ischemia modified albumin in early diabetic nephropathy

Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 7, Issue 2

Abstract

Background: Ischemia and hypoxia are observed in diabetic patients in addition to chronic hyperglycemia and intensified oxidative stress. It is reflected by increased markers levels of oxidative protein damage, especially in patients with vascular complications, as well as ischemia−modified albumin (IMA). Objective: To assess the plasma levels of IMA in T2DM patients with early diabetic nephropathy and their relationship with routine markers of kidney disease severity (urinary microalbumin, plasma creatinine concentration) Materials And Methods: Plasma IMA levels were manually determined in 100 patients and 50 healthy people by spectrophotometric Co(II)−albumin binding assay. Micoalbuminuria was detected using turbidimetric method and creatinine using Jaffe’s method in Cobas Autoanalyzer Results: The IMA levels in the diabetic patients were significantly higher than in the healthy controls and increased progressively with the degree of DN. The normoalbuminuria group 1 had the lowest IMA level, which significantly increased with development of microalbuminuria and as nephropathy progressed in group 2 and group 3. There were significant relationships between IMA and microalbuminuria (r = 0.87) Conclusion: This study indicates that the observed increased IMA in T2DM is connected with diabetic nephropathy. Measuring IMA plasma levels provided additional information about nephropathy development and it may be helpful in assessing the severity of oxidative stress, which causes kidney dysfunction at an early stage.

Authors and Affiliations

Mukherjee Brijesh, Sahoo Sibasish

Keywords

Related Articles

Duration of type 2 diabetes mellitus as a threat indicator for the microalbuminuria; A signal for diabetic nephropathy

Background: Diabetes mellitus is one of the major health problem leading to the long term kidney damage and responsible for 30-40% of all chronic kidney diseases. Aim and Objectives: The study was conducted to find the a...

Serum lipid profile in oral submucous fibrosis - A case control study

Background: Oral Sub Mucous Fibrosis (OSMF) is a chronic, debilitating disease characterised by juxtaepithelial fibrosis of the oral cavity. It is a precancerous condition a generalized pathological state of the oral muc...

Altered activity of lecithin cholesterol ACYL transferase enzyme and high density lipoprotein in type 2 diabetes mellitus

An important enzyme in modulating plasma HDL levels is cholesterol acyl transferase (LCAT) which is responsible for the formation of most of the cholesterol esters (CE) present in human plasma. This enzyme catalyses the...

Serum uric acid, serum iron levels in normal pregnancy and preeclampsia patients

Objective: Preeclampsia is pregnancy specific syndrome of reduced organ perfusion, secondary to vasospasm and endothelial activation associated with edema, BP: 140/90mm of Hg after 20 weeks of gestation and most frequent...

Adenosine deaminase levels in serum and cerebrospinal fluid of patients with tuberculous meningitis

Background: Tuberculosis is one of the oldest human diseases with the highest mortality rate among infectious diseases and is caused by bacteria Mycobacterium tuberculosis complex and usually affects the lungs, although...

Download PDF file
  • EP ID EP410291
  • DOI -
  • Views 211
  • Downloads 0

How To Cite

Mukherjee Brijesh, Sahoo Sibasish (2018). Ischemia modified albumin in early diabetic nephropathy. Medpulse International Journal of Biochemistry, 7(2), 46-50. https://europub.co.uk/articles/-A-410291